About Intercept

Who we are

Intercept is a biopharmaceutical company focused on the development and commercialisation of novel therapeutics to treat progressive non-viral liver diseases.

Contact Intercept

International Headquarters
Two Pancras Square
Kings Cross, London,

T: +44 203 805 7600
E: info@interceptpharma.com

For all specific application queries, please email the Practice to Policy® Health Awards team. 

Page update code and date: EU-NP-N/A-0282 | April 2020